Compare Stocks

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AKU Akumin		$0.18	$0.12 ▼ $1.90	$26.32M	-0.72	1.38 million shs	8.54 million shs
ONC Oncolytics Biotech	C$1.47 +2.8%	C$1.44	C$1.20 ▼ C$4.49	C$110.87M	1.49	77,454 shs	29,418 shs
SQD SQI Diagnostics	C$0.02	C$0.02	C$0.01 ▼ C$0.18	C$6.11M	-0.21	172,133 shs	65,000 shs
VPT VentriPoint Diagnostics	C$0.21 -4.5%	C$0.25	C$0.12 ▼ C$0.36	C$32.93M	0.39	99,266 shs	83,000 shs

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AKU Akumin	0.00%	0.00%	0.00%	0.00%	-53.87%
ONC Oncolytics Biotech	-2.05%	-2.72%	+3.62%	-13.86%	-8.92%
SQD SQI Diagnostics	0.00%	0.00%	0.00%	0.00%	-66.67%
VPT VentriPoint Diagnostics	+4.76%	0.00%	-4.35%	-26.67%	+46.67%

The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AKU Akumin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	0.5878 of 5 stars	3.5	0.0	0.0	0.0	1.1	0.0	0.0
SQD SQI Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AKU Akumin	1.50	Reduce	$0.25	∞ Upside
ONC Oncolytics Biotech	3.00	Buy	C$6.00	308.16% Upside
SQD SQI Diagnostics	N/A	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest ONC, SQD, AKU, YGEN, and VPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	ONC Oncolytics Biotech	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform	C$3.00

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AKU Akumin	$749.63M	0.00	N/A	N/A	$1.24 per share	0.00
ONC Oncolytics Biotech	N/A	N/A	C$0.35 per share	4.22	C$0.37 per share	N/A
SQD SQI Diagnostics	C$3.04M	2.01	C$0.00 per share	8.50	C($0.04) per share	-0.38
VPT VentriPoint Diagnostics	C$24.60K	1,338.71	C$0.04 per share	5.53	C$0.01 per share	21.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AKU Akumin	-$156.76M	-$2.52	N/A	N/A	N/A	-30.56%	-167.86%	-7.81%	N/A
ONC Oncolytics Biotech	-C$27.75M	-C$0.41	N/A	∞	N/A	N/A	-102.66%	-55.47%	5/3/2024 (Estimated)
SQD SQI Diagnostics	-C$19.14M	-C$0.05	N/A	∞	N/A	N/A	N/A	-74.70%	6/4/2024 (Estimated)
VPT VentriPoint Diagnostics	-C$4.74M	-C$0.03	N/A	∞	N/A	N/A	-141.63%	-63.46%	5/2/2024 (Estimated)

Latest ONC, SQD, AKU, YGEN, and VPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/7/2024	Q4 2023	ONC Oncolytics Biotech	-C$0.15	-C$0.05	+C$0.10	-C$0.05	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AKU Akumin	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	N/A	N/A	N/A	N/A	N/A
SQD SQI Diagnostics	N/A	N/A	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AKU Akumin	17.02	0.99	0.99
ONC Oncolytics Biotech	1.54	9.01	8.86
SQD SQI Diagnostics	464.33	0.12	0.40
VPT VentriPoint Diagnostics	32.61	2.06	6.67

Ownership

Institutional Ownership

Company	Institutional Ownership
AKU Akumin	36.10%
ONC Oncolytics Biotech	6.98%
SQD SQI Diagnostics	25.15%
VPT VentriPoint Diagnostics	N/A

Insider Ownership

Company	Insider Ownership
AKU Akumin	20.51%
ONC Oncolytics Biotech	6.24%
SQD SQI Diagnostics	50.20%
VPT VentriPoint Diagnostics	1.93%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AKU Akumin	3,631	91.17 million	72.47 million	Not Optionable
ONC Oncolytics Biotech	29	75.42 million	N/A	Not Optionable
SQD SQI Diagnostics	147,000	407.17 million	N/A	Not Optionable
VPT VentriPoint Diagnostics	147,000	156.82 million	N/A	Not Optionable

ONC, SQD, AKU, YGEN, and VPT Headlines

Source	Headline
	Insider Buying: VentriPoint Diagnostics Ltd. (CVE:VPT) Director Buys 75,000 Shares of Stock insidertrades.com - April 23 at 4:36 AM
	VentriPoint Diagnostics (CVE:VPT) Trading Up 4.8% americanbankingnews.com - April 17 at 1:50 AM
	VentriPoint Diagnostics Ltd VPT morningstar.com - April 14 at 8:55 AM
	Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call finance.yahoo.com - March 28 at 10:36 AM
	Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use stockhouse.com - March 4 at 1:29 PM
	VentriPoint Diagnostics Stock (OTC:VPTDF) Dividends: History, Yield and Dates benzinga.com - February 21 at 6:59 PM
	Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences thenewswire.com - February 20 at 3:23 PM
	VentriPoint Diagnostics Ltd VPTDF morningstar.com - February 14 at 8:46 AM
	Ventripoint Announces Changes to The Board of Directors thenewswire.com - February 13 at 3:04 PM
	Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales stockhouse.com - February 13 at 10:03 AM
	The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System es-us.finanzas.yahoo.com - February 1 at 12:00 PM
	The 2023 Year in Review finance.yahoo.com - January 29 at 2:50 PM
	Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board thenewswire.com - January 22 at 1:13 AM
	Ventripoint Whitepaper Distribution: thenewswire.com - January 3 at 1:30 PM
	Healthcare Stock Rallies Strongly Following Key Implementation theglobeandmail.com - December 12 at 3:45 PM
	Ollie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's Hospitals finance.yahoo.com - December 5 at 9:22 AM
	Editorial: EV diagnostic process should become industry standard autonews.com - November 21 at 11:55 PM
	In 2026, EVs will have an industry standard diagnostic system autonews.com - November 14 at 9:07 PM
	Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference thenewswire.com - November 9 at 8:59 AM
	Accelerate Diagnostics Inc AXDX morningstar.com - November 5 at 6:39 PM
	Quest Diagnostics Reviews consumeraffairs.com - October 15 at 6:11 PM
	Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference thenewswire.com - October 12 at 10:38 AM
	Ventripoint Diagnostics appoints Jimmy Jeon as CFO seekingalpha.com - October 4 at 2:44 PM
	Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium thenewswire.com - September 8 at 2:16 PM

New MarketBeat Followers Over Time

Top Headlines

Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
April 2, 2024 9:15 AM
View Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
April 2, 2024 11:25 AM
View Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
April 5, 2024 8:45 AM
View Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
March 26, 2024 7:00 AM
View Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
Cannabis: One Stock to Play the Movement
April 8, 2024 8:38 AM
View Cannabis: One Stock to Play the Movement

All Headlines

Company Descriptions

Akumin

NASDAQ:AKU

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Oncolytics Biotech

TSE:ONC

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

SQI Diagnostics

CVE:SQD

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

VentriPoint Diagnostics

CVE:VPT

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial